Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The abdomen (excluding a two-inch radius around the navel), front and outer thighs, and back of the upper arms all provide suitable injection sites with adequate subcutaneous tissue
Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field
Available treatments: GLP-1 weight loss treatment Bloodwork for weight loss These injections support energy, fat metabolism, and appetite control under clinical supervision
The authors used a meta-analysis of 11 randomised controlled trials incorporating 1024 patients
Bookmark our Peptide FDA Compounding Status Tracker 2026 for the latest category and PCAC updates on every peptide
Injection site reactions Lipohypertrophy, irritation, redness, and bruising can occur at injection sites
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
